NEW YORK (Reuters Health) – Vedolizumab does not appear to worsen COVID-19 outcomes in patients with inflammatory bowel disease (IBD),
Home ยป
besthealthtale.com
Home ยป
NEW YORK (Reuters Health) – Vedolizumab does not appear to worsen COVID-19 outcomes in patients with inflammatory bowel disease (IBD),